Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Leschly: Tough competitor at work and play

Terry Macalister
Tuesday 20 January 1998 19:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

If Jan Leschly succeeds in a bid to create the world's largest healthcare group, his commercial prowess could finally eclipse his other great successes: on the tennis courts.

The 57-year-old chief executive of SmithKline Beecham was ranked tenth in the world at tennis 30 years ago. He played 16 consecutive Wimbledon tournaments and was a regular choice for his native Denmark in the Davis Cup.

Mr Leschly works at business like he played tennis: to win. Outspoken and fiercely competitive, he has been deeply influenced by the US where he now officially lives with his family.

Although educated with a pharmacy degree and MBA from university in Copenhagen, Mr Leschly joined the US-based pharmaceutical group, Squibb Corporation, where he quickly climbed the corporate ladder.

In 1990, Mr Leschly took his American-style openness and keen sense of humour to SB as chairman of the group's worldwide pharmaceutical business. His enormous reserves of energy were used by the then group chief executive, Bob Bauman, to help weld together the still disparate pieces of the recently merged SmithKline and Beecham companies.

Mr Leschly succeeded Mr Bauman in April 1994 and immediately embarked on a whirlwind of activity. In a single year he completed either the sale or purchase of assets worth $10bn (pounds 6.1bn).

Now based in Philadelphia and also on the board of American Express, Mr Leschly has attracted little but praise for his strong corporate leadership. The only real carping has surrounded the size of his pay packet: he earned more than pounds 2m in 1996 which included a pounds 1.2m bonus.

Co-operative in management style, Mr Leschly nevertheless likes to lead from the front. As one colleague remarked: "It probably comes from being the nephew of two Danish generals."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in